Description: Prenetics Limited, a DNA biotechnology company, specializes in pharmacogenomics. The company develops iGenes PGx test that enables physicians to help patients identify the right drug, right dosage, and to list out potential adverse drug effects based on one's genetic profile. Its iGenes PGx test is used to test cardiovascular, psychiatric, pain, hypersensitivity, and commonly prescribed drugs. The company also offers ONEdna, a DNA screening test service that provides a view and analysis of an individual's genes along with actionable recommendations. The company has strategic partnerships with The Lippo Group and New Horizon Health Limited. Prenetics Limited was formerly known as Multigene Diagnostics Limited and changed its name to Prenetics Limited in November 2014. The company was incorporated in 2007 and is based in Central, Hong Kong.
Home Page: www.partnerre.com
PRE Technical AnalysisExchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Insurance |
| GIC Industry: | Insurance |
| GIC Sub-Industry: | Reinsurance |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.48 |
| IPO Date: | 2022-05-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 800 |